Ann Arbor, MI · Founded 2014 · Privately Held (backing)
Developer of genome interpretation software designed to improve cancer diagnosis and treatment. Genomenon is based in Ann Arbor, MI and was founded in 2014. Its last known valuation is $68 million. It has raised $36.8 million across 4 recorded rounds; the latest was a $5.5 million early-stage round in May 2024.
Last price · $/share
—
Implied valuation
$68.0M
Total raised
$36.8M
Last round
Early Stage VC
May 2024
Team — not yet on record
No current team members for Genomenon are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genomenon with a free account
·The complete investor list: 25 names
·Watch Genomenon: the Monday email on marks, rounds and moves
